(Q39458050)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

New alkyl-lipid blockers of SK3 channels reduce cancer cell migration and occurrence of metastasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Philippe Bougnoux

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Virginie Joulin

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

J-P Haelters

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

M Potier-Cartereau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

A Chantome

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

M Pinault

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

S Marionneau-Lambot

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

T Oullier

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

G Simon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

H Couthon-Gourvès

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

P-A Jaffrès

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

B Corbel

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

C Vandier

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

1 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

Current Cancer Drug Targets

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21999627%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

1111-1125

1 reference